Pro-Dex, Inc.

    Jurisdiction
    United States
    LEI
    529900EB2AJA079NT411
    ISIN
    US74265M2052 (PDEX)
    Sectors
    1. Healthcare
    2. Medical - Instruments & Supplies

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. Read full profile

    Fundamentals

    Net revenue
    €56.80M
    Gross margin
    29.3%
    EBIT
    €9.12M
    EBIT margin
    16.1%
    Net income
    €7.66M
    Net margin
    13.5%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €59.71M +5.1% €7.16M -6.4%
    N/A N/A
    N/A N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 15K $755.60K +500 Buy

    Earnings Calls

    Latest earnings call: November 13, 2014 (Q1 2015)

    Add to watchlist

    Notifications